Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Telomir Pharmaceuticals Inc (NASDAQ: TELO) was $1.56 for the day, up 1.96% from the previous closing price of $1.53. In other words, the price has increased by $1.96 from its previous closing price. On the day, 0.87 million shares were traded. TELO stock price reached its highest trading level at $1.58 during the session, while it also had its lowest trading level at $1.46.
Ratios:
Our analysis of TELO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on February 21, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TELO now has a Market Capitalization of 52776308 and an Enterprise Value of 49697424.
Stock Price History:
The Beta on a monthly basis for TELO is -0.53, which has changed by -0.7790368 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, TELO has reached a high of $8.40, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -0.67%, while the 200-Day Moving Average is calculated to be -47.54%.
Shares Statistics:
TELO traded an average of 4.55M shares per day over the past three months and 1290940 shares per day over the past ten days. A total of 30.51M shares are outstanding, with a floating share count of 16.79M. Insiders hold about 47.99% of the company’s shares, while institutions hold 8.70% stake in the company. Shares short for TELO as of 1756425600 were 3249510 with a Short Ratio of 0.71, compared to 1753920000 on 1592821. Therefore, it implies a Short% of Shares Outstanding of 3249510 and a Short% of Float of 13.73.
Earnings Estimates
The market rating of Telomir Pharmaceuticals Inc (TELO) is currently shaped by the ongoing analysis conducted by 1 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.38 and -$0.38 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.28, with 1.0 analysts recommending between -$0.28 and -$0.28.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $1.5M in the next fiscal year. The high estimate is $1.5M and the low estimate is $1.5M.
